High expression of heat shock proteins and heat shock factor-1 distinguishes an aggressive subset of clear cell renal cell carcinoma.

about

High expression of heat shock proteins and heat shock factor-1 distinguishes an aggressive subset of clear cell renal cell carcinoma.

Item

http://www.wikidata.org/entity/Q47855849

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

High expression of heat shock ...... ear cell renal cell carcinoma.

@en

High expression of heat shock ...... ear cell renal cell carcinoma.

@nl

type

Item

label

High expression of heat shock ...... ear cell renal cell carcinoma.

@en

High expression of heat shock ...... ear cell renal cell carcinoma.

@nl

prefLabel

High expression of heat shock ...... ear cell renal cell carcinoma.

@en

High expression of heat shock ...... ear cell renal cell carcinoma.

@nl

P1476

High expression of heat shock ...... lear cell renal cell carcinoma

@en

P2093

Pao-Shu Wu

http://www.w3.org/2001/XMLSchema#string

Yen-Hwa Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Cells in stress: transcriptional activation of heat shock genes

Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy

Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view.

Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Protein expression profiling in the spectrum of renal cell carcinomas.

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial.

Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.

Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings

Prognostic models with competing risks: methods and application to coronary risk prediction.

P304

711-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIS.13284

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chin-Chen Pan

P577

2017-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28617974

http://www.w3.org/2001/XMLSchema#string